420,630 Shares in Herbalife Ltd $HLF Bought by Invenomic Capital Management LP

Invenomic Capital Management LP purchased a new stake in Herbalife Ltd (NYSE:HLF) in the 3rd quarter, HoldingsChannel reports. The fund purchased 420,630 shares of the company’s stock, valued at approximately $3,550,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Fund 1 Investments LLC acquired a new position in Herbalife during the second quarter worth $8,491,000. Optimize Financial Inc acquired a new position in shares of Herbalife during the third quarter valued at about $511,000. Iridian Asset Management LLC CT increased its position in shares of Herbalife by 9.9% during the third quarter. Iridian Asset Management LLC CT now owns 2,449,155 shares of the company’s stock worth $20,671,000 after acquiring an additional 220,896 shares in the last quarter. CenterBook Partners LP acquired a new stake in shares of Herbalife in the 3rd quarter worth about $368,000. Finally, GSA Capital Partners LLP acquired a new stake in shares of Herbalife in the 3rd quarter worth about $911,000.

Herbalife Price Performance

HLF opened at $15.28 on Tuesday. Herbalife Ltd has a fifty-two week low of $6.20 and a fifty-two week high of $20.40. The firm has a market capitalization of $1.58 billion, a P/E ratio of 6.94, a PEG ratio of 0.92 and a beta of 0.83. The company’s 50-day moving average is $16.80 and its 200 day moving average is $12.66.

Herbalife (NYSE:HLF) last issued its quarterly earnings data on Wednesday, February 18th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.03). The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.24 billion. Herbalife had a negative return on equity of 35.02% and a net margin of 4.53%.The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.36 earnings per share. On average, equities research analysts expect that Herbalife Ltd will post 1.57 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have issued reports on HLF. Citigroup reiterated a “buy” rating and set a $21.00 price target (up from $17.00) on shares of Herbalife in a research note on Thursday, February 19th. Maxim Group assumed coverage on Herbalife in a research note on Tuesday, January 6th. They issued a “buy” rating and a $20.00 price objective for the company. Wall Street Zen upgraded Herbalife from a “hold” rating to a “buy” rating in a report on Friday, November 28th. Argus set a $15.00 target price on Herbalife in a research report on Wednesday, November 26th. Finally, Mizuho set a $13.00 price target on Herbalife and gave the stock a “neutral” rating in a report on Thursday, January 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Herbalife currently has a consensus rating of “Moderate Buy” and a consensus target price of $16.60.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.